Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Opeyemi Babatunde Ogunsuyi, Folorunsho Bright Omage, Olawande Chinedu Olagoke, Ganiyu Oboh & João Batista Teixeria Rocha. (2023) Phytochemicals from African eggplants (Solanum macrocarpon L) and Black nightshade (Solanum nigrum L) leaves as acetylcholinesterase inhibitors: an in-silico study. Journal of Biomolecular Structure and Dynamics 41:16, pages 7725-7734.
Read now
Read now
Anas Shamsi, Moyad Al Shahwan, Shahzaib Ahamad, Md. Imtaiyaz Hassan, Faizan Ahmad & Asimul Islam. (2020) Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer’s drug donepezil with human transferrin: implications of Alzheimer’s drug. Journal of Biomolecular Structure and Dynamics 38:4, pages 1094-1102.
Read now
Read now
Lu Liu, Ming-Xu Tang, Xia-Nan Sang, Shao-Fei Chen, Xiao-Jie Lu, Yu-Bo Wang, Ying-Ying Si, Hai-Feng Wang, Gang Chen & Yue-Hu Pei. (2019) Three new tetralol analogs from soil-derived fungus Myrothecium verrucaria with anti-inflammatory activity. Journal of Asian Natural Products Research 21:1, pages 33-42.
Read now
Read now
Yo Han Kim, Hee Youn Choi, Hyeong-Seok Lim, Shi Hyang Lee, Hae Sun Jeon, Donghyun Hong, Seong Su Kim, Young Kweon Choi & Kyun-Seop Bae. (2015) Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers. Drug Design, Development and Therapy 9, pages 1419-1426.
Read now
Read now
Weiwei Zhu, Zhanchou Zhang, Jingfeng Qi, Fang Liu, Jindong Chen, Jingping Zhao & Xiaofeng Guo. (2014) Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study. Neuropsychiatric Disease and Treatment 10, pages 1317-1323.
Read now
Read now
Arif Nisha Syad & Kasi Pandima Devi. (2014) Botanics: a potential source of new therapies for Alzheimer's disease?. Botanics: Targets and Therapy 4, pages 11-26.
Read now
Read now
Filip Zemek, Lucie Drtinova, Eugenie Nepovimova, Vendula Sepsova, Jan Korabecny, Jiri Klimes & Kamil Kuca. (2014) Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opinion on Drug Safety 13:6, pages 759-774.
Read now
Read now
K.V. Dileep, C. Remya, I. Tintu & C. Sadasivan. (2013) Designing of multi-target-directed ligands against the enzymes associated with neuroinflammation: an in silico approach. Frontiers in Life Science 7:3-4, pages 174-185.
Read now
Read now
Alicja Skrzypek, Joanna Matysiak, Monika M. Karpińska & Andrzej Niewiadomy. (2013) Synthesis and anticholinesterase activities of novel 1,3,4-thiadiazole based compounds. Journal of Enzyme Inhibition and Medicinal Chemistry 28:4, pages 816-823.
Read now
Read now
Gonzalo Emiliano Aranda-Abreu, María Elena Hernández-Aguilar, Jorge Manzo Denes, Luis Isauro García Hernández & Marisol Herrera Rivero. (2011) Rehabilitating a brain with Alzheimer’s: a proposal. Clinical Interventions in Aging 6, pages 53-59.
Read now
Read now
Articles from other publishers (54)
Wafaa A. Helmy, Tamer I.M. Ragab, Bassem M. Salama, Mona Basha, Rehab Shamma, Sahar S. Abd El-Rahman & Heba Shawky. (2023) Novel naringin tablet formulations of agro-resides based nano/micro crystalline cellulose with neuroprotective and Alzheimer ameliorative potentials. International Journal of Biological Macromolecules 231, pages 123060.
Crossref
Crossref
Jun-Rui Pang, Sher-Wei How, Kah-Hui Wong, Siew-Huah Lim, Siew-Moi Phang & Yoon-Yen Yow. (2022) Cholinesterase inhibitory activities of neuroprotective fraction
derived from red alga Gracilaria manilaensis. Fisheries and Aquatic Sciences 25:2, pages 49-63.
Crossref
Crossref
Olalekan Olanrewaju Bakare, Adewale Oluwaseun Fadaka, Musa Oyebowale Akanbi, Kolajo Adedamola Akinyede, Ashwil Klein & Marshall Keyster. (2021) Evaluation of selected carotenoids of Lycopersicon esculentum variants as therapeutic targets for ‘Alzheimer’s disease: an in silico approach. BMC Molecular and Cell Biology 22:1.
Crossref
Crossref
Hiroshi Todaka, Mikihiko Arikawa, Tatsuya Noguchi, Atsushi Ichikawa & Takayuki Sato. (2021) Donepezil, an anti-Alzheimer's disease drug, promotes differentiation and regeneration in injured skeletal muscle through the elevation of the expression of myogenic regulatory factors. European Journal of Pharmacology 911, pages 174528.
Crossref
Crossref
Mingoo Bae, Seung Yon Han, Eun-Sun Kim, Byung Hoon You, Young-Mi Kim, Jungsook Cho, Young-Won Chin & Young Hee Choi. (2021) Effect of Water Extract of Mangosteen Pericarp on Donepezil Pharmacokinetics in Mice. Molecules 26:17, pages 5246.
Crossref
Crossref
Kana Okada, Kayo Nishizawa, Tomoko Kobayashi, Shogo Sakata, Kouichi Hashimoto & Kazuto Kobayashi. (2021) Different cholinergic cell groups in the basal forebrain regulate social interaction and social recognition memory. Scientific Reports 11:1.
Crossref
Crossref
Giovanni Ribaudo, Maurizio Memo & Alessandra Gianoncelli. (2021) Multi-target Natural and Nature-Inspired Compounds against Neurodegeneration: A Focus on Dual Cholinesterase and Phosphodiesterase Inhibitors. Applied Sciences 11:11, pages 5044.
Crossref
Crossref
Koula Doukani, Ammar Sidi Mohammed Selles & Hasna Bouhenni. 2021. Naturally Occurring Chemicals Against Alzheimer's Disease. Naturally Occurring Chemicals Against Alzheimer's Disease
225
241
.
Monica A. Silva, Alessandra S. Kiametis & Werner Treptow. (2020) Donepezil Inhibits Acetylcholinesterase via Multiple Binding Modes at Room Temperature. Journal of Chemical Information and Modeling 60:7, pages 3463-3471.
Crossref
Crossref
Dohyun Kim, Tae Hee Han, Seong-Chul Hong, Sun Jae Park, Yong Hak Lee, Hyeongmin Kim, Minwoo Park & Jaehwi Lee. (2020) PLGA Microspheres with Alginate-Coated Large Pores for the Formulation of an Injectable Depot of Donepezil Hydrochloride. Pharmaceutics 12:4, pages 311.
Crossref
Crossref
Saida Haider, Laraib Liaquat, Saara Ahmad, Zehra Batool, Rafat Ali Siddiqui, Saiqa Tabassum, Sidrah Shahzad, Sahar Rafiq & Narjis Naz. (2020) Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress. PLOS ONE 15:1, pages e0227631.
Crossref
Crossref
Muhammad Saeed Jan, Sajjad Ahmad, Fida Hussain, Ashfaq Ahmad, Fawad Mahmood, Umer Rashid, Obaid-ur-Rahman Abid, Farhat Ullah, Muhammad Ayaz & Abdul Sadiq. (2020) Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents. European Journal of Medicinal Chemistry 186, pages 111863.
Crossref
Crossref
Norifumi Tsuno, Takahiro Mori, Ichiro Ishikawa, Nobuyasu Bando, Haeyoung Park, Yoshito Matsumoto, Itsuko Mori, Mariko Tanaka, Takayuki Hirano & Yu Nakamura. (2019) Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study. Geriatrics & Gerontology International 19:7, pages 571-576.
Crossref
Crossref
James T. BrewsterIIII, Simone Dell’Acqua, Danny Q. Thach & Jonathan L. Sessler. (2018) Classics in Chemical Neuroscience: Donepezil. ACS Chemical Neuroscience 10:1, pages 155-167.
Crossref
Crossref
Weenawan Somphon, Anittha Prasertsabw & Nongpanga Jarussophon. (2019) Novel cogrinding of donepezil with neurotransmitters and coumarins: characterization, physical properties and in vitro drug release study. Materials Today: Proceedings 17, pages 1887-1897.
Crossref
Crossref
Katrine Skovgård, Claus Agerskov, Kristi A. Kohlmeier & Kjartan F. Herrik. (2018) The 5-HT3 receptor antagonist ondansetron potentiates the effects of the acetylcholinesterase inhibitor donepezil on neuronal network oscillations in the rat dorsal hippocampus. Neuropharmacology 143, pages 130-142.
Crossref
Crossref
Odunayo Michael Agunloye & Ganiyu Oboh. (2018) Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil. Journal of Complementary and Integrative Medicine 15:1.
Crossref
Crossref
Kinga Gawel, Ewa Gibula-Bruzda, Marcin Dziedzic, Malgorzata Jenda-Wojtanowska, Marta Marszalek-Grabska, Jerzy Silberring & Jolanta H. Kotlinska. (2017) Cholinergic activation affects the acute and chronic antinociceptive effects of morphine. Physiology & Behavior 169, pages 22-32.
Crossref
Crossref
Mikihiko Arikawa, Yoshihiko Kakinuma, Tatsuya Noguchi, Hiroshi Todaka & Takayuki Sato. (2016) Donepezil, an acetylcholinesterase inhibitor, attenuates LPS-induced inflammatory response in murine macrophage cell line RAW 264.7 through inhibition of nuclear factor kappa B translocation. European Journal of Pharmacology 789, pages 17-26.
Crossref
Crossref
Minsook Ye, Hwan-Suck Chung, Yong Ho An, Su-jin Lim, Won Choi, A. Ram Yu, Jin Su Kim, Manho Kang, Seunghun Cho, Insop Shim & Hyunsu Bae. (2015) Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer?s Disease. Molecular Neurobiology 53:8, pages 5401-5412.
Crossref
Crossref
Olivier Beauchet, John Barden, Teresa Liu-Ambrose, Victoria L. Chester, Cedric Annweiler, Tony Szturm, Sébastien Grenier, Guillaume Léonard, Louis Bherer & Gilles Allali. (2016) Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial. Drugs & Aging 33:9, pages 665-673.
Crossref
Crossref
Kjartan F. Herrik, Arne Mørk, Nelly Richard, Christoffer Bundgaard, Jesper F. Bastlund & Inge E.M. de Jong. (2016) The 5-HT 6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus. Neuropharmacology 107, pages 351-363.
Crossref
Crossref
Hazem Eimar, Sharifa Alebrahim, Garthiga Manickam, Ahmed Al-Subaie, Lina Abu-Nada, Monzur Murshed & Faleh Tamimi. (2016) Donepezil regulates energy metabolism and favors bone mass accrual. Bone 84, pages 131-138.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
215
225
.
Takashi Kudo, Kenneth L. Davis, Rafael Blesa Gonzalez & David George WilkinsonTakashi Kudo. 2016. Practical Pharmacology for Alzheimer’s Disease. Practical Pharmacology for Alzheimer’s Disease
119
135
.
Vivien Kauschke, Mathias Kneffel, Wolfgang Floel, Sonja Hartmann, Marian Kampschulte, Lutz Dürselen, Anita Ignatius, Reinhard Schnettler, Christian Heiss & Katrin Susanne Lips. (2015) Bone status of acetylcholinesterase-knockout mice. International Immunopharmacology 29:1, pages 222-230.
Crossref
Crossref
Omar M. E. Abdel-Salam, Eman R. Youness, Fatma A. Morsy, Marwa M. Mahfouz & Sanaa A. Kenawy. (2014) Study of the effect of antidepressant drugs and donepezil on aluminum-induced memory impairment and biochemical alterations in rats. Comparative Clinical Pathology 24:4, pages 847-860.
Crossref
Crossref
Maviye Galipoğlu, Meryem Sedef Erdal & Sevgi Güngör. (2014) Biopolymer-Based Transdermal Films of Donepezil as an Alternative Delivery Approach in Alzheimer’s Disease Treatment. AAPS PharmSciTech 16:2, pages 284-292.
Crossref
Crossref
Sharad Kumar Suthar & Manu Sharma. (2015) Recent Developments in Chimeric NSAIDs as Safer Anti-Inflammatory Agents. Medicinal Research Reviews 35:2, pages 341-407.
Crossref
Crossref
O. Beauchet, C. P. Launay, G. Allali & C. Annweiler. (2014) Changes in Gait Variability with Anti-dementia Drugs: A Systematic Review and Meta-analysis. CNS Drugs 28:6, pages 513-518.
Crossref
Crossref
Olivier Beauchet, Cyrille P. Launay, Gilles Allali, François R. Herrmann & Cedric Annweiler. (2014) Gait Changes with Anti-Dementia Drugs: A Prospective, Open-Label Study Combining Single and Dual Task Assessments in Patients with Alzheimer’s Disease. Drugs & Aging 31:5, pages 363-372.
Crossref
Crossref
Vageesh Revadigar, Raza Murad Ghalib, Vikneswaran Murugaiyah, Mohamed A. Embaby, Ali Jawad, Sayed Hasan Mehdi, Rokiah Hashim & Othman Sulaiman. 2014. Drug Design and Discovery in Alzheimer's Disease. Drug Design and Discovery in Alzheimer's Disease
142
198
.
Olivier Beauchet, Cyrille P Launay, Gazan Allali, Gilles Watfa, Karim Gallouj, François R Herrmann & Cédric Annweiler. (2013) Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study. BMC Neurology 13:1.
Crossref
Crossref
Margarita Gutiérrez, María Francisca Matus, Tomas Poblete, Jessica Amigo, Gabriel Vallejos & Luis Astudillo. (2013) Isoxazoles: synthesis, evaluation and bioinformatic design as acetylcholinesterase inhibitors. Journal of Pharmacy and Pharmacology 65:12, pages 1796-1804.
Crossref
Crossref
Alicja Skrzypek, Joanna Matysiak, Andrzej Niewiadomy, Marek Bajda & Paweł Szymański. (2013) Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors. European Journal of Medicinal Chemistry 62, pages 311-319.
Crossref
Crossref
Ting Liu, Zheng Xia, Wei-Wei Zhang, Jian-rong Xu, Xin-Xing Ge, Juan Li, Yongyao Cui, Zhui-Bai Qiu, Jun Xu, Qiong Xie, Hao Wang & Hong-Zhuan Chen. (2013) Bis(9)-(−)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice. Pharmacology Biochemistry and Behavior 104, pages 138-143.
Crossref
Crossref
Faviola Alc?ntara-Gonz?lez, Claudia Rebeca Mendoza-Perez, N?stor Zaragoza, Ismael Juarez, Luis Enrique Arroyo-Garc?a, Citlalli Gamboa, Fidel De La Cruz, Sergio Zamudio, Fernando Garcia-Dolores & Gonzalo Flores. (2012) Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice. Synapse 66:11, pages 938-949.
Crossref
Crossref
Valentina Echeverria & Ross Zeitlin. (2012) Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease. CNS Neuroscience & Therapeutics 18:7, pages 517-523.
Crossref
Crossref
Katja S. Kroker, Georg Rast, Riccardo Giovannini, Anelise Marti, Cornelia Dorner-Ciossek & Holger Rosenbrock. (2012) Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. Neuropharmacology 62:5-6, pages 1964-1974.
Crossref
Crossref
Gareth Maher-Edwards, Ruth Dixon, Jackie Hunter, Michael Gold, Gillian Hopton, Gemma Jacobs, Jo Hunter & Pauline Williams. (2011) SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study. International Journal of Geriatric Psychiatry 26:5, pages 536-544.
Crossref
Crossref
Orazio Nicolotti, Leonardo Pisani, Marco Catto, Francesco Leonetti, Ilenia Giangreco, Angela Stefanachi & Angelo Carotti. (2011) Discovery of a Potent and Selective Hetero-Bivalent AChE Inhibitor via Bioisosteric Replacement. Molecular Informatics 30:2-3, pages 133-136.
Crossref
Crossref
R. Scott Bitner, Stella Markosyan, Arthur L. Nikkel & Jorge D. Brioni. (2011) In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer?s disease. Neuropharmacology 60:2-3, pages 460-466.
Crossref
Crossref
Douglas J. Sheffler, Karen J. Gregory, Jerri M. Rook & P. Jeffrey Conn. 2011. Pharmacology of G Protein Coupled Receptors. Pharmacology of G Protein Coupled Receptors
37
77
.
Marta Sochocka, Ewa Zaczy?ska, Agnieszka Tabo?Anna Czarny, Jerzy Leszek & Maciej Sobczy?ski. (2010) The influence of donepezil and EGb 761 on the innate immunity of human leukocytes. International Immunopharmacology 10:12, pages 1505-1513.
Crossref
Crossref
Zhe Jin, Liu Yang, Si-Jie Liu, Jian Wang, Shuo Li, Huang-Quan Lin, David Chi Cheong Wan & Chun Hu. (2010) Synthesis and biological evaluation of 3,6-diaryl-7H-thiazolo[3,2-b] [1,2,4]triazin-7-one derivatives as acetylcholinesterase inhibitors. Archives of Pharmacal Research 33:10, pages 1641-1649.
Crossref
Crossref
Romain Le Cozannet, Kevin C. F. Fone & Paula M. Moran. (2010) Phencyclidine withdrawal disrupts episodic-like memory in rats: reversal by donepezil but not clozapine. The International Journal of Neuropsychopharmacology 13:08, pages 1011-1020.
Crossref
Crossref
Subas Sakya & Kapil Karki. 2010. Modern Drug Synthesis. Modern Drug Synthesis
249
274
.
Sherri Young, Karine Fabio, Christophe Guillon, Pramod Mohanta, Timothy A. Halton, Diane E. Heck, Robert A. FlowersIIII, Jeffrey D. Laskin & Ned D. Heindel. (2010) Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunction. Bioorganic & Medicinal Chemistry Letters 20:9, pages 2987-2990.
Crossref
Crossref
Shahin Akhondzadeh, Mehdi Shafiee Sabet, Mohammad Hossein Harirchian, Mansoreh Togha, Hamed Cheraghmakani, Soodeh Razeghi, Seyyed Shamssedin Hejazi, Mohammad Hossein Yousefi, Roozbeh Alimardani, Amirhossein Jamshidi, Shams-Ali Rezazadeh, Aboulghasem Yousefi, Farhad Zare, Atbin Moradi & Ardalan Vossoughi. (2009) A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology 207:4, pages 637-643.
Crossref
Crossref
Deanna M. Barch. 2010. Behavioral Neurobiology of Schizophrenia and Its Treatment. Behavioral Neurobiology of Schizophrenia and Its Treatment
43
96
.
Faviola Alcantara-Gonzalez, Ismael Juarez, Oscar Solis, Isaura Martinez-Tellez, Israel Camacho-Abrego, Eliezer Masliah, Raul Mena & Gonzalo Flores. (2010) Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration. Synapse, pages NA-NA.
Crossref
Crossref
D. Holland, J. B. Brewer, D. J. Hagler, C. Fennema-Notestine & A. M. Dale. (2009) Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proceedings of the National Academy of Sciences 106:49, pages 20954-20959.
Crossref
Crossref
QingChuan Zheng, HuiYing Chu, RuiJuan Niu & ChiaChung Sun. (2009) Theoretical studies of interaction models of human acetylcholine esterase with different inhibitors. Science in China Series B: Chemistry 52:11, pages 1911-1916.
Crossref
Crossref
Keith D. Green, Micha Fridman & Sylvie Garneau-Tsodikova. (2009) hChAT: A Tool for the Chemoenzymatic Generation of Potential Acetyl/Butyrylcholinesterase Inhibitors. ChemBioChem 10:13, pages 2191-2194.
Crossref
Crossref